These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8113322)

  • 1. Motor performance, histologic damage, and calcium influx in rats treated with NBQX after focal ischemia.
    DeGraba TJ; Ostrow P; Hanson S; Grotta JC
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):262-8. PubMed ID: 8113322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction.
    Xue D; Huang ZG; Barnes K; Lesiuk HJ; Smith KE; Buchan AM
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):251-61. PubMed ID: 7509339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, NBQX, after focal ischaemia in the rat.
    Smith SE; Meldrum BS
    Funct Neurol; 1993; 8(1):43-8. PubMed ID: 8330753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the AMPA-receptor antagonist, NBQX, on neuron loss in dentate hilus of the hippocampal formation after 8, 10, or 12 min of cerebral ischemia in the rat.
    Hu P; Diemer NH; Bruhn T; Johansen FF
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):147-52. PubMed ID: 9040493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of isradipine, an L-type calcium channel blocker on permanent and transient focal cerebral ischemia in spontaneously hypertensive rats.
    Campbell CA; Mackay KB; Patel S; King PD; Stretton JL; Hadingham SJ; Hamilton TC
    Exp Neurol; 1997 Nov; 148(1):45-50. PubMed ID: 9398449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PBN) and N-tert-butyl-(2-sulfophenyl)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia.
    Yang Y; Li Q; Shuaib A
    Exp Neurol; 2000 May; 163(1):39-45. PubMed ID: 10785442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
    Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
    J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed antagonism of AMPA/kainate receptors reduces long-term functional deficits resulting from spinal cord trauma.
    Wrathall JR; Teng YD; Marriott R
    Exp Neurol; 1997 Jun; 145(2 Pt 1):565-73. PubMed ID: 9217092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with an AMPA antagonist 12 hours following severe normothermic forebrain ischemia prevents CA1 neuronal injury.
    Li H; Buchan AM
    J Cereb Blood Flow Metab; 1993 Nov; 13(6):933-9. PubMed ID: 7691852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA)/kainate antagonists and their role in cerebral ischaemia.
    Gill R
    Cerebrovasc Brain Metab Rev; 1994; 6(3):225-56. PubMed ID: 7529037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia.
    Matucz E; Móricz K; Gigler G; Simó A; Barkóczy J; Lévay G; Hársing LG; Szénási G
    Brain Res; 2004 Sep; 1019(1-2):210-6. PubMed ID: 15306255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methylprednisolone treatment in experimental focal cerebral ischemia.
    Slivka AP; Murphy EJ
    Exp Neurol; 2001 Jan; 167(1):166-72. PubMed ID: 11161604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of periinfarct direct current shifts with glutamate antagonist NBQX following occlusion of the middle cerebral artery in the rat.
    Mies G; Kohno K; Hossmann KA
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):802-7. PubMed ID: 8063875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose-response study of neuroprotection using the AMPA antagonist NBQX in rat focal cerebral ischemia.
    Graham SH; Chen J; Lan JQ; Simon RP
    J Pharmacol Exp Ther; 1996 Jan; 276(1):1-4. PubMed ID: 8558416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors.
    Zhang F; Iadecola C
    J Cereb Blood Flow Metab; 1994 Jul; 14(4):574-80. PubMed ID: 8014203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. -(S)-Alpha-phenyl-2-pyridine-ethanamine Dihydrochloride-, a low affinity uncompetitive N-methyl-D-aspartic acid antagonist, is effective in rodent models of global and focal ischemia.
    Cregan EF; Peeling J; Corbett D; Buchan AM; Saunders J; Auer RN; Gao M; Mccarthy DJ; Eisman MS; Campbell TM; Murray RJ; Stagnitto ML; Palmer GC
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1412-24. PubMed ID: 9400017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia.
    Zhang F; White JG; Iadecola C
    J Cereb Blood Flow Metab; 1994 Mar; 14(2):217-26. PubMed ID: 8113318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of vineatrol in focal cerebral ischemia in rats.
    Briyal S; Sharma U; Jagannathan NR; Gupta YK
    Methods Find Exp Clin Pharmacol; 2009 Oct; 31(8):505-11. PubMed ID: 19967099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the AMPA receptor antagonist NBQX on outcome of newborn pigs after asphyxic cardiac arrest.
    Brambrink AM; Martin LJ; Hanley DF; Becker KJ; Koehler RC; Traystman RJ
    J Cereb Blood Flow Metab; 1999 Aug; 19(8):927-38. PubMed ID: 10458600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of glutamate receptors in the development and maintenance of bladder overactivity after cerebral infarction in the rat.
    Yokoyama O; Mizuno H; Komatsu K; Akino H; Tanase K; Namiki M
    J Urol; 2004 Apr; 171(4):1709-14. PubMed ID: 15017271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.